Detalhe da pesquisa
1.
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
Clin Infect Dis
; 76(5): 861-870, 2023 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259527
2.
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial.
Clin Infect Dis
; 77(7): 991-1009, 2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207617
3.
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study.
J Antimicrob Chemother
; 78(4): 933-945, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36775983
4.
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial.
J Med Virol
; 95(9): e29114, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752816
5.
Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in Italy.
Sex Transm Infect
; 99(1): 53-56, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443987
6.
Pillars of long-term antiretroviral therapy success.
Pharmacol Res
; 196: 106898, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648103
7.
Inflammation and vascular dysfunction: The negative synergistic combination of diabetes and COVID-19.
Diabetes Metab Res Rev
; 38(7): e3565, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35830597
8.
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort.
HIV Med
; 22(9): 843-853, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34318591
9.
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study.
J Med Virol
; 93(3): 1421-1427, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32776534
10.
Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study.
BMC Infect Dis
; 21(1): 595, 2021 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157984
11.
Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease.
J Antimicrob Chemother
; 75(11): 3334-3343, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32737482
12.
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study.
J Antimicrob Chemother
; 75(1): 194-199, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31605107
13.
Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy.
J Med Virol
; 92(9): 1637-1640, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32222993
14.
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study.
Pharmacol Res
; 158: 104931, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32446978
15.
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.
Pharmacol Res
; 158: 104899, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32407959
16.
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting.
J Antimicrob Chemother
; 74(5): 1363-1367, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30698801
17.
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection.
J Med Virol
; 91(10): 1891-1895, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31199538
18.
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience.
J Women Aging
; 31(2): 176-188, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-29369016
19.
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study.
BMC Med
; 16(1): 79, 2018 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29807541
20.
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial.
J Antimicrob Chemother
; 73(7): 1955-1964, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29668978